The FDA has even accredited a drug created with cannabidiol for that purpose (Epidiolex). Although the company only endorses it for two rare varieties of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome. In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify marijuana like a https://psychoactive-cannabinoids45555.jiliblog.com/91769349/little-known-facts-about-potent-thc-strains